How do we define non-eligible for Platinum in Ovarian Cancer: Impact of prior therapies and novel strategies for treatment - Industry Symposium by Novocure
Back to course
Video Transcription
Video Summary
Keywords
symposium
non-eligibility
platinum-based therapy
ovarian cancer
Novacure
Ju-Ju Foundation
panel of speakers
PARP resistance
combination therapies
replication fork
research
biomarker-driven studies
Contact education@igcs.org for assistance.
Powered By